PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Nanoparticles disguised as red blood cells will deliver cancer-fighting drugs

2011-06-21
(Press-News.org) Researchers at the University of California, San Diego have developed a novel method of disguising nanoparticles as red blood cells, which will enable them to evade the body's immune system and deliver cancer-fighting drugs straight to a tumor. Their research will be published next week in the online Early Edition of the Proceedings of the National Academy of Sciences.

The method involves collecting the membrane from a red blood cell and wrapping it like a powerful camouflaging cloak around a biodegradable polymer nanoparticle stuffed with a cocktail of small molecule drugs. Nanoparticles are less than 100 nanometers in size, about the same size as a virus.

"This is the first work that combines the natural cell membrane with a synthetic nanoparticle for drug delivery applications." said Liangfang Zhang, a nanoeningeering professor at the UC San Diego Jacobs School of Engineering and Moores UCSD Cancer Center. "This nanoparticle platform will have little risk of immune response".

Researchers have been working for years on developing drug delivery systems that mimic the body's natural behavior for more effective drug delivery. That means creating vehicles such as nanoparticles that can live and circulate in the body for extended periods without being attacked by the immune system. Red blood cells live in the body for up to 180 days and, as such, are "nature's long-circulation delivery vehicle," said Zhang's student Che-Ming Hu, a UCSD Ph.D. candidate in bioengineering, and first author on the paper.

Stealth nanoparticles are already used successfully in clinical cancer treatment to deliver chemotherapy drugs. They are coated in a synthetic material such as polyethylene glycol that creates a protection layer to suppress the immune system so that the nanoparticle has time to deliver its payload. Zhang said today's stealth nanoparticle drug delivery vehicles can circulate in the body for hours compared to the minutes a nanoparticle might survive without this special coating.

But in Zhang's study, nanoparticles coated in the membranes of red blood cells circulated in the bodies of lab mice for nearly two days. The study was funded through a grant from the National Institute of Health.

A shift towards personalized medicine Using the body's own red blood cells marks a significant shift in focus and a major breakthrough in the field of personalized drug delivery research. Trying to mimic the most important properties of a red blood cell in a synthetic coating requires an in-depth biological understanding of how all the proteins and lipids function on the surface of a cell so that you know you are mimicking the right properties. Instead, Zhang's team is just taking the whole surface membrane from an actual red blood cell.

"We approached this problem from an engineering point of view and bypassed all of this fundamental biology," said Zhang. "If the red blood cell has such a feature and we know that it has something to do with the membrane -- although we don't fully understand exactly what is going on at the protein level -- we just take the whole membrane. You put the cloak on the nanoparticle, and the nanoparticle looks like a red blood cell."

Using nanoparticles to deliver drugs also reduces the hours it takes to slowly drip chemotherapy drug solutions through an intravenous line to just a few minutes for a single injection of nanoparticle drugs. This significantly improves the patient's experience and compliance with the therapeutic plan. The breakthrough could lead to more personalized drug delivery wherein a small sample of a patient's own blood could produce enough of the essential membrane to disguise the nanoparticle, reducing the risk of immune response to almost nothing.

Zhang said one of the next steps is to develop an approach for large-scale manufacturing of these biomimetic nanoparticles for clinical use, which will be done through funding from the National Science Foundation. Researchers will also add a targeting molecule to the membrane that will enable the particle to seek and bind to cancer cells, and integrate the team's technology for loading drugs into the nanoparticle core so that multiple drugs can be delivered at the same time.

Zhang said being able to deliver multiple drugs in a single nanoparticle is important because cancer cells can develop a resistance to drugs delivered individually. By combining them, and giving the nanoparticle the ability to target cancer cells, the whole cocktail can be dropped like a bomb from within the cancer cell.

### END


ELSE PRESS RELEASES FROM THIS DATE:

New study reveals how the immune system responds to hepatitis A virus

2011-06-21
A surprising finding in a study comparing hepatitis C virus (HCV) with hepatitis A virus (HAV) infections in chimpanzees by a team that includes scientists from the Texas Biomedical Research Institute sheds new light on the nature of the body's immune response to these viruses. Understanding how hepatitis C becomes chronic is very important because some 200 million people worldwide and 3.2 million people in the U.S. are chronically infected with HCV and are at risk for progression to cirrhosis and liver cancer. Hepatitis C associated liver disease is the most common ...

Adulterated cocaine causing serious skin reactions

Adulterated cocaine causing serious skin reactions
2011-06-21
LOS ANGELES—(June 20, 2011)—Doctors warned of a potential public health epidemic in a recent report on patients in Los Angeles and New York who developed serious skin reactions after smoking or snorting cocaine believed to be contaminated with a veterinary medication drug dealers are using to dilute, or "cut," up to 70% of the cocaine in the U.S. The report, published online in the Journal of the American Academy of Dermatology, said six patients developed purple-colored patches of necrotic skin on their ears, nose, cheeks and other parts of their body and, in some instances, ...

Australian Sun Protective Wear Now Available in the U.S.

Australian Sun Protective Wear Now Available in the U.S.
2011-06-21
Solartex Sun Gear, Inc., a leader in sun protective clothing in the United States, is introducing its newest line that provides the maximum (50+) SPF/UPF in sun protection. Designed in Australia, these colorful rash shirts, swimsuits and hats come in a full range of sizes from 0 to 8xl, offering something for everyone from the newborn to the plus-sized adult. Since its founding in 1998, Solartex has specialized in locating, importing, manufacturing, and retailing sun protective UV clothing to U.S. and international consumers. It is now designing and manufacturing private ...

3 postulates to help identify the cause of Alzheimer's disease

2011-06-21
Amsterdam, The Netherlands, June 20, 2011 -- After more than 100 years following its pathologic description, the cause of Alzheimer's disease (AD) remains unknown. To test the validity of present and future proposals related to the probable cause of AD, three postulates, or necessary conditions, are recommended by Jack de la Torre, MD, PhD, Adjunct Professor of Psychology at the University of Texas, Austin, in an article published in the Journal of Alzheimer's Disease. "Knowing what causes AD is critically important because it would allow more effective therapy to specifically ...

Unexpected function of dyslexia gene

2011-06-21
Scientists at Karolinska Institutet in Sweden have discovered that a gene linked to dyslexia has a surprising biological function: it controls cilia, the antenna-like projections that cells use to communicate. Dyslexia is largely hereditary and linked to a number of genes, the functions of which are, however, largely unknown. This present study from Karolinska Institutet and Helsinki University now shows that one of these genes, DCDC2, is involved in regulating the signalling of cilia in brain neurons. "Our discovery presents us with a possible new neurobiological ...

Research reveals that 10 percent of middle-aged Europeans are on antidepressants

Research reveals that 10 percent of middle-aged Europeans are on antidepressants
2011-06-21
New research from the University of Warwick and the IZA Institute in Bonn shows that 10% of middle-aged Europeans took antidepressants in 2010. The researchers looked in detail at the lives of a randomly selected sample of nearly 30,000 Europeans. The study covered 27 countries. Andrew Oswald, an economics professor at the University of Warwick, and co-author of the study, described the results as concerning, he said: "Antidepressants are a relatively new kind of commodity. We are only starting to get proper data on who takes them. But as we live in the richest and safest ...

Let your fingers do the talking: Sexting and infidelity in cyberspace

2011-06-21
Although sex and infidelity are now only a keyboard away, at the end of the day, there is no substitute for physical, face-to-face contact in our sexual relationships. That's according to a new study by Diane Kholos Wysocki, from the University of Nebraska at Kearney, and Cheryl Childers, from Washburn University in Topeka, Kansas. They investigated the behaviors of infidelity on the internet and sexting - sending sexually explicit text messages and photographs via email or cell phone. Their findings are published online in Springer's journal, Sexuality & Culture. The ...

WSO2 Summer School Features Free Class on Integrating FIX Applications Within Financial Firms' Heterogeneous Environments

WSO2 Summer School Features Free Class on Integrating FIX Applications Within Financial Firms Heterogeneous Environments
2011-06-21
Financial services firms rely on the Financial Information eXchange (FIX) protocol to drive the real-time electronic exchange of securities transactions. However, the special message format and rigid nature of the FIX protocol mean it often interoperates poorly with non-FIX applications. The combination of the WSO2 Enterprise Service Bus (WSO2 ESB) and FIX protocol support provides a powerful solution for seamlessly integrating FIX applications and the heterogeneous systems supporting a financial firm's operations. IT architects and developers can learn how to optimize ...

UC research provides prescription for healthier hospital supply chains

UC research provides prescription for healthier hospital supply chains
2011-06-21
University of Cincinnati analysis of hospital supply chains – how hospitals stock nursing stations with the hundreds of medicines, materials and even office supplies needed – holds promise in helping to make supply and re-supply efforts leaner and more cost effective. The research, to be presented June 22 at the Institute for Operations Research and Management Science Healthcare Conference in Montreal, has implications for affecting the significant costs associated with hospital supplies. On average, supplies and inventory account for 30 to 40 percent of an average hospital's ...

Karlsruhe Institute of Technology: Self-assembling electronic nano-components

Karlsruhe Institute of Technology: Self-assembling electronic nano-components
2011-06-21
Magnetic storage media such as hard drives have revolutionized the handling of information: We are used to dealing with huge quantities of magnetically stored data while relying on highly sensitive electronic components. And hope to further increase data capacities through ever smaller components. Together with experts from Grenoble and Strasbourg, researchers of KIT's Institute of Nanotechnology (INT) have developed a nano-component based on a mechanism observed in nature. What if the very tininess of a component prevented one from designing the necessary tools for its ...

LAST 30 PRESS RELEASES:

When devices can read human emotions without a camera

Warming temperatures impact immune performance of wild monkeys, U-M study shows

Fine particulate air pollution may play a role in adverse birth outcomes

Sea anemone study shows how animals stay ‘in shape’

KIER unveils catalyst innovations for sustainable turquoise hydrogen solutions

Bacteria ditch tags to dodge antibiotics

New insights in plant response to high temperatures and drought

Strategies for safe and equitable access to water: a catalyst for global peace and security

CNIO opens up new research pathways against paediatric cancer Ewing sarcoma by discovering mechanisms that make it more aggressive

Disease severity staging system for NOTCH3-associated small vessel disease, including CADASIL

Satellite evidence bolsters case that climate change caused mass elephant die-off

Unique killer whale pod may have acquired special skills to hunt the world’s largest fish

Emory-led Lancet review highlights racial disparities in sudden cardiac arrest and death among athletes

A new approach to predicting malaria drug resistance

Coral adaptation unlikely to keep pace with global warming

Bioinspired droplet-based systems herald a new era in biocompatible devices

A fossil first: Scientists find 1.5-million-year-old footprints of two different species of human ancestors at same spot

The key to “climate smart” agriculture might be through its value chain

These hibernating squirrels could use a drink—but don’t feel the thirst

New footprints offer evidence of co-existing hominid species 1.5 million years ago

Moral outrage helps misinformation spread through social media

U-M, multinational team of scientists reveal structural link for initiation of protein synthesis in bacteria

New paper calls for harnessing agrifood value chains to help farmers be climate-smart

Preschool education: A key to supporting allophone children

CNIC scientists discover a key mechanism in fat cells that protects the body against energetic excess

Chemical replacement of TNT explosive more harmful to plants, study shows

Scientists reveal possible role of iron sulfides in creating life in terrestrial hot springs

Hormone therapy affects the metabolic health of transgender individuals

Survey of 12 European countries reveals the best and worst for smoke-free homes

First new treatment for asthma attacks in 50 years

[Press-News.org] Nanoparticles disguised as red blood cells will deliver cancer-fighting drugs